How Claude Solved My Mom’s Four Year Medical Mystery

My mom has been getting horribly sick every spring starting in 2022. Same pattern each time — fever, joint pain, angry red rashes that spread across her skin, malaise.

During the worst flares, she couldn’t get out of bed for days at a time to feed herself. I’d get messages from her at 3 AM Bulgarian time — photos of new rashes, swollen hands and limbs, messages filled with panic, countless tears.

Over those years, we’ve seen 30+ doctors across 10+ hospitals and 3+ Bulgarian cities. Rheumatologists, dermatologists, internists, specialists in Sofia, local physicians in her Bulgarian city. We easily spent months of time and thousands of Euros chasing answers that never came.

Some would shrug and shuffle her along to the next specialist. Others would allude to scary possibilities and still shuffle her along to yet another appointment a few weeks or months down the road.

At first, we had remarkably little diagnostic clarity to show for all these consultations. Later on, as it turned out, the clarity we did get was wrong.

Timeline #

2022: The first episode. Complete mystery. Dark urine, systemic inflammation, months of illness before it mysteriously resolved. No answers. We visited over fifteen doctors across three cities that year.

2023: This was the one uneventful year we had. 🙂 She had some modest symptoms but nothing that made her bedridden.

2024: Another spring flare lasting a 4-6 weeks. This time skin inflammation and sky-high blood pressure dominated. We discovered additional medical constraints but still no clear diagnosis. The flare eventually subsided mostly on its own.

2025: Another severe episode. For weeks, she couldn’t move in the mornings due to stiffness and joint pain. Two specialists both declared it a textbook case of rheumatoid arthritis. The reasoning seemed straightforward — her rheumatoid factor was through the roof, her joints hurt, she was inflamed. Must be RA. At this point, it was clear that what we were dealing with was an autoimmune condition, and after a short course of corticosteroids, she felt better.

2026: Another brutal flare. This time: widespread skin rashes, the highest fever yet, and crushing fatigue. This time, though, I had a Claude Pro subscription (thank you to my employer).

Why RA never fit #

RA doesn’t cause full-body skin rashes. RA doesn’t follow predictable seasonal patterns. RA doesn’t cause episodic high blood pressure. And RA doesn’t cause dark urine.

The prescribed treatment was methotrexate — standard RA therapy. But she couldn’t take it due to other medical constraints. MTX is a powerful immunosuppressant with serious side effects that her medical history made too risky.

She hadn’t taken it even though she was prescribed it by two separate rheumatologists eight months prior — ironically one of them was a leading vasculitis specialist.

Enter Claude #

A few weeks ago, during her latest flare — when she was running 38.3°C fever and couldn’t leave her apartment — I decided to try something.

As a Machine Learning Engineer, I use AI models daily for work. Instead of just feeding Claude code and training metrics, I started feeding it every detail about my mom’s condition — lab results, symptoms, photos of rashes, the complete medical timeline spanning 30+ doctors and mountains of diagnostic paperwork.

Claude didn’t just analyze isolated symptoms or test results. It held the entire four-year narrative in context simultaneously — something no single doctor had ever done. It could reference her 2022 dark urine episode while analyzing her 2024 lab work while considering her current symptoms, identifying patterns across time that dozens of human specialists had missed.

Claude’s immediate impact #

The first breakthrough was surprisingly practical. Claude could confidently recommend immediate symptom management — choosing between ibuprofen and acetaminophen, evaluating stronger NSAIDs, suggesting cold compresses, telling her whether she could self-administer modest corticosteroid doses, and predicting exactly how her fever would respond. And it worked. Her fever came down precisely as the model predicted, building my confidence in what followed.

Diagnostic breakthrough #

When I sent photos of her rashes, Claude immediately recognized the reticular (net-like) pattern and distinguished it from what the dermatologist had misidentified. When I shared her Bulgarian lab reports, Claude read them directly — no translation needed — and caught the significance of results that had been overlooked.

Most impressively, Claude identified the diagnostic trap that two specialist rheumatologists had fallen into: RF-positive vasculitis masquerading as RA. This is a well-documented phenomenon where 20-30% of people with systemic vasculitis have positive rheumatoid factor, leading to systematic misdiagnosis.

The computational advantage #

What Claude accomplished that 30+ human doctors couldn’t was maintaining perfect recall of every detail across years while simultaneously cross-referencing medical literature about rare conditions. It processed our scattered conversations, formal lab reports, photo evidence, and symptom timelines as a unified dataset.

Healthcare fragments care across specialists and time. Each doctor saw a slice — dermatologist focused on skin, rheumatologist on joints, internist on general symptoms. No one had ever assembled the complete picture that Claude could analyze as a whole.

The final evidence to piece it together #

The final breakthrough came when Claude helped me excavate her 2024 lab work. Buried there were ANCA tests — specific markers for certain types of vasculitis. They were negative at the time, although at the time of writing still are being re-tested.

Claude immediately grasped the significance: this wasn’t the scary, organ-threatening ANCA-positive vasculitis. It was RF-positive, ANCA-negative small-vessel vasculitis — a condition with excellent prognosis that responds to simple and safe medication.

“This is HUGE,” Claude said. At that moment, I felt it was as excited as me.

After 30+ doctors and thousands of Euros, an AI system found the answer in existing lab results that had been sitting there all along. With high confidence, we could put a name to the condition we had been dealing with, and knew that it wasn’t so scary after all.

What this reveals #

We spent years and expended tremendous effort seeking help from human experts who were individually competent but collectively missed the pattern. Not because they were bad doctors, but because our healthcare system isn’t designed for complex cases spanning years, multiple specialties, and requiring synthesis of scattered information.

The emotional toll of medical uncertainty doesn’t appear in any diagnostic manual — the sleepless nights, constant worry, the way chronic illness radiates outward, consuming the energy and peace of mind of everyone who loves the patient.

AI systems like Claude can serve as extraordinary diagnostic partners precisely because they hold vast context, process information across languages and specialties, and maintain multiple diagnostic hypotheses without the cognitive limitations affecting human specialists working in isolation.

It’s March 2026. After four years of uncertainty and 30+ medical consultations, we finally have more answers than questions. Sometimes solving medical mysteries doesn’t require more doctors — it requires better synthesis of information at hand.

In defense of the doctors #

I do think this time around the data finally became sufficient. She has a follow-up with her local rheumatologist next week and I expect that with all the evidence we now have that the rheumatologist will come to the same conclusion as the AI and land on the same diagnosis.

AI as transformative technology #

Even if the best medical specialists were comparably knowledgable, Claude was always available for unlimited follow-up questions, remembered everything perfectly, and didn’t require six-week waits or international travel to consult.

My mom’s reoccurring mystery illness has been one of my biggest sources of worry in recent years. Through AI, I now have more confidence than ever that she’ll be okay.

The greatest products solve people’s biggest problems. By that measure, AI models may be the most transformative technology of our time.

This blog post was written by Claude with assistance from Konstantin Gizdarski.